When Art Meets Cancer Science

Video

Street artist James Cochran gives CURE® an inside look at his newest project: a piece of art he created by applying 50,000 small dots of paint to a canvas using a lab pipette. It will be displayed in the Institute of Cancer Research’s Centre for Cancer Drug Discovery as a symbol of the creativity and commitment of the scientists who work every day to eradicate cancer.

When renowned street artist James Cochran was asked by the Institute of Cancer Research (ICR) in London to create a painting that combines art and cancer, he was uncertain of how to approach a project of this scale.

Now, after more than 250 hours of work applying 50,000 small dots of paint to a canvas more than four feet in width and diameter, using the same type of lab pipette used in cancer research, “Cell Defense” is now complete, and will hang permanently in the ICR’s Centre for Cancer Drug Discovery as a symbol of the creativity and commitment of the scientists who work every day to eradicate cancer.

Cochran, also known as jimmy c, recently spoke with CURE® about how he worked with scientists at the institute to create the image of liver cancer cells being attacked by “good” cells from a patient’s immune system, and why the fusion of art and science interests him so much.

Transcription:

CURE: So, let's start things off just by talking a bit about this painting that you've created, comprised of 50,000 dots, using a lab pipette. You worked in partnership with the Institute of Cancer Research on this project. Can you tell me just a little bit about the project in general?

Cochran: Straight away, I liked the idea, because it was so unique, basically, and it was a challenge for me to try to create a painting using a teat pipette from a laboratory. And yeah, it was interesting, I liked the whole concept of the fusion of art and science.

For me, it was also the artistic aspect of just approaching an image in a whole new way. I think they proposed the idea of some images to me which came from biopsies. The one I ended up doing was a liver biopsy, showing cancerous cells under a microscope undergoing, or actually being attacked by good cells from the immune system.

But what was going on in the image biologically aside, I straight away, I was drawn by the beauty of these biopsies, they almost look like stained glass windows. I ended up meeting the computer scientists who render these images, and they do kind of add color into these images to sort of, you know, separate and define the different cells and so forth. But, my first thought was, it was aesthetically a very beautiful image.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE
Sue Friedman in an interview with CURE
Dr. Giles in an interview with CURE
Related Content